Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

NCT05703854 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Advanced Renal Cell Carcinoma
Advanced Mesothelioma
Advanced Osteosarcoma

Interventions

DRUG: CAR.70/IL15-transduced CB-derived NK cells
DRUG: Fludarabine phosphate
DRUG: Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center